Starting in 2027, the controversial drug middlemen will have to share a broad swath of fee and compensation data with self-funded employer clients.
DOL finalizes sweeping pharmacy benefit manager disclosure rule
Starting in 2027, the controversial drug middlemen will have to share a broad swath of fee and compensation data with self-funded employer clients.